Drug Development

Zephyr AI Raises $18.5M to Advance Precision Medicine, Drug Discovery

March 31, 2022 - Zephyr AI, a health IT startup, landed $18.5 million in seed round funding to advance precision medicine and drug discovery through machine learning and extensive data sets. The $18.5 million round was led by Lerner Group Investments LLC and M-Cor Holdings, with participants from Allen Y Chao, AME Cloud...


More Articles

AI Drug Discovery Platform IDs Potential COVID-19 Treatments

by Samantha McGrail

A drug discovery platform powered by artificial intelligence (AI) technology has identified 18 potential treatments for COVID-19, according to an announcement from health IT company Gero. Six of the...